Impact

Our solutions are implemented and embedded in real-world healthcare settings to improve cancer care for patients, clinicians, and communities.

Impact Statistics

2 Years

Patients who are progression-free on immunotherapy for NSCLC can stop therapy at 2 years and don’t need indefinite therapy.

13.5%

Increase in serious illness conversations resulting from machine learning-based nudges

91%

Reduction in time to action when patients use e-consults for blood disorders.

2024 Annual Impact Report

Each year, we highlight projects that create, test, and scale innovative solutions that enhance the patient and clinician experience; increase care efficiency and value; and improve health outcomes in patients with cancer.

Read the Report

Get Involved

Become part of our impact, stay informed on our change agents’ latest innovations, and/or explore educational opportunities at the University of Pennsylvania.

Get Involved